重症患者における急性肝不全・急性腎傷害・代謝異常

出版社： 中山書店
著者：
発行日： 2018-03-10
分野： 臨床医学：一般  >  救命/救急
ISBN： 9784521743349
電子書籍版： 2018-03-10 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

11,000 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

11,000 円(税込)

購入する

商品紹介

救急・集中治療領域では，ハイリスク患者の長期的な生命予後も含めた生活の質の向上に関心が高まっている．本書では，対応の遅れが予後を不良とする代表的な病態である急性肝不全，急性腎傷害（AKI），電解質・代謝・酸塩基平衡異常を取り上げ，人工肝補助療法（ALS）や血液浄化療法，薬物療法，栄養管理などの治療法を中心に詳しく解説．臨床に活かせる最新情報を1冊にまとめた．

目次

  • 1章　急性肝不全の病態
    2章　急性肝不全の治療
    3章　急性腎障害の定義・診断
    4章　急性腎障害の治療
    5章　電解質・代謝異常
    6章　酸塩基平衡異常

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

[ 急性肝不全 ]

P.11 掲載の参考文献
1) 持田智. 急性肝不全-概念, 診断基準と我が国における実態. 日消誌 2015 ; 112 : 813-21.
 
2) 厚生労働省「難治性の肝・胆道疾患に関する調査研究」班, 編. 劇症肝炎の診療ガイド. 東京 : 文光堂 ; 2010. p.2-8.
 
3) 日本肝臓学会 肝炎診療ガイドライン作成委員会, 編. B型肝炎治療ガイドライン. 第2.2版. 東京 : 日本肝臓学会 ; 2016. p.62-5. https://www.jsh.or.jp/files/uploads/HBV_GL_ver2.2_May30.pdf
 
4) 持田智. 我が国における急性肝不全および遅発性肝不全 (LOHF) の実態 (2014年) -平成27年度全国調査. 厚生労働科学研究費補助金 (難治性疾患等政策研究事業) 難治性の肝・胆道疾患に関する調査研究班. 分担研究報告書. 2016. p.116-35.
 
5) 持田智. 我が国における急性肝不全および遅発性肝不全 (LOHF) の実態 (2013年) -平成26年度全国調査. 厚生労働科学研究費補助金 (難治性疾患等政策研究事業) 難治性の肝・胆道疾患に関する調査研究班. 分担研究報告書. 2015. p.92-109.
 
6) 持田智. 劇症肝炎に関する研究. 厚生労働科学研究費補助金 (難治性疾患等政策研究事業) 難治性の肝・胆道疾患に関する調査研究班. 総合研究報告書. 2014. p.29-44.
 
7) 持田智. 急性肝不全の病態と治療. 臨牀と研究 2017 ; 94 : 56-60.
 
8) 古藤和浩, 高柳涼一. ステロイド動注療法を用いた劇症肝炎の新たな治療戦略. 福岡医誌 2010 ; 101 : 109-18.
 
9) Oketani M, et al. Etiology and prognosis of fulminant hepatitis and late-onset hepatic failure in Japan : Summary of the annual nationwide survey between 2004 and 2009. Hepatol Res 2013 ; 43 : 97-105.
PubMed
10) Bernal W, et al. Acute liver failure : A curable disease by 2024? J Hepatol 2015 ; 62 : S112-20.
PubMed
11) 藤原慶一, ほか. 急性肝不全に対する人工肝補助療法についての提言 : high-flow CHDF, on-line HDFによる覚醒率向上の認識とその全国標準化の必要性. 肝臓 2014 ; 55 : 79-81.
 
12) Bernal W, Wendon J. Acute Liver Failure. N Engl J Med 2013 ; 369 : 2525-34.
PubMed
13) Naiki T, et al. Novel scoring system as a useful model to predict the outcome of patients with acute liver failure : Application to indication criteria for liver transplantation. Hepatol Res 2012 ; 42 : 68-75.
PubMed
P.23 掲載の参考文献
1) 荒瀬康司, 熊田博光. 急性ウイルス性肝炎. 小川聡, 総編集. 内科学書. 改訂第8版. 4 消化管・腹膜疾患 肝・胆道・膵疾患. 東京 : 中山書店 : 2013. p.250-7.
 
2) 厚生労働省「難治性の肝・胆道疾患に関する調査研究」班, 編. 劇症肝炎の診療ガイド. 東京 : 文光堂 ; 2010.
 
3) 持田智. 厚生労働省「難治性の肝・胆道疾患に関する調査研究」班. 急性肝不全 (劇症肝炎・LOHF) 全国調査集計結果 (2010～2015年). 研究報告書. 2017.
 
4) 日本肝移植研究会. 肝移植症例登録報告. 移植 2016 ; 51 : 145-59.
 
P.30 掲載の参考文献
1) Lewis JH, Kleiner D. Hepatic injury due to drugs, herbal compounds, chemicals and toxins. In : Burt AD, et al, eds. MacSween's Pathology of the Liver. 6th ed. Philadelphia : Elsevier, Churchill Livingstone ; 2012. p.645-760.
 
2) 堀池典生, ほか. 薬物性肝障害の実態-全国集計. 恩地森一, 監修. 薬物性肝障害の実態. 東京 : 中外医学社 ; 2008. p.1-10.
 
3) Onji M, et al. Clinical characteristics of drug-induced liver injury in the elderly. Hepatol Res 2009 ; 39 : 546-52.
PubMed
4) Lammert C, et al. Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury : Search for signals. Hepatology 2008 ; 47 : 2003-9.
PubMed
5) Russmann S, et al. Current concepts of mechanisms in drug-induced hepatotoxicity. Curr Med Chem 2009 ; 16 : 3041-53.
PubMed
6) 滝川一, ほか. DDW-J 2004 ワークショップ薬物性肝障害診断基準の提案. 肝臓 2005 ; 46 (2) : 85-90. https://www.jsh.or.jp/doc/guidelines/dil05.pdf
 
7) 厚生労働省. 重篤副作用疾患別対応マニュアル. 薬物性肝障害 (肝細胞障害型薬物性肝障害, 胆汁うっ滞型薬物性肝障害, 混合型薬物性肝障害, 急性肝不全, 薬物起因の他の肝疾患). 平成20年4月. http://www.mhlw.go.jp/topics/2006/11/dl/tp1122-1i01.pdf
 
8) 厚生労働省. 「難治性の肝・胆道疾患に関する調査研究」班 : 2009年. 劇症肝炎の肝移植適応ガイドライン : スコアリングシステム. http://www.hepatobiliary.jp/uploads/files/表4%281%29.pdf
 
P.41 掲載の参考文献
1) Kenjo A, et al. Risk stratification of 7,732 hepatectomy cases in 2011 from the National Clinical Database for Japan. J Am Coll Surg 2014 ; 218 : 412-22.
PubMed
2) Yasunaga H, et al. Relationship between hospital volume and operative mortality for liver resection : Data from the Japanese Diagnosis Procedure Combination database. Hepatol Res 2012 ; 42 : 1073-80.
PubMed
3) Abulkhir A, et al. Preoperative portal vein embolization for major liver resection : A meta-analysis. Ann Surg 2008 ; 247 : 49-57.
PubMed
4) Sakamoto T, et al. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology 1999 ; 29 : 403-11.
PubMed
5) Garcea G, Maddern GJ. Liver failure after major hepatic resection. J Hepatobiliary Pancreat Surg 2009 ; 16 : 145-55.
PubMed
6) 日本肝癌研究会追跡調査委員, 編. 第19回全国原発性肝癌追跡調査報告 (2006-2007). 肝臓 2016 ; 57 : 45-73.
 
7) Belghiti J, et al. Seven hundred forty-seven hepatectomies in the 1990s : An update to evaluate the actual risk of liver resection. J Am Coll Surg 2000 ; 191 : 38-46.
PubMed
8) Balzan S, et al. The "50-50 Criteria" on postoperative day 5 : An accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005 ; 242 : 824-8.
PubMed
9) Rahbari NN, et al. Posthepatectomy liver failure : A definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 2011 ; 149 : 713-24.
 
10) 日本肝癌研究会, 編. 臨床・病理 原発性肝癌取扱い規約. 第6版. 東京 : 金原出版 ; 2015. p.15.
 
11) 日本肝臓学会, 編. 科学的根拠に基づく肝癌診療ガイドライン 2013年版. 第3版. 東京 : 金原出版 ; 2013. p. 76-8.
 
12) 幕内雅敏, ほか. 肝硬変合併肝癌治療のStrategy. 外科診療 1987 ; 29 : 1530-6.
 
13) Nagino M, et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer : Surgical outcome and long-term follow-up. Ann Surg 2006 ; 243 : 364-72.
PubMed
14) Tsuruga Y, et al. Significance of functional hepatic resection rate calculated using 3D CT/ (99m) Tc-galactosyl human serum albumin single-photon emission computed tomography fusion imaging. World J Gastroenterol 2016 ; 22 : 4373-9.
PubMed
15) Kishi Y, et al. Three hundred and one consecutive extended right hepatectomies : Evaluation of outcome based on systematic liver volumetry. Ann Surg 2009 ; 250 : 540-48.
PubMed
16) Solomkin JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children : Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010 ; 50 : 133-64.
 
17) Boerema I, et al. Life without blood. A study of the influence of high atmospheric pressure and hypothermia on dilution of the blood. J Cardiovasc Surg 1960 ; 1 : 133-46.
 
P.49 掲載の参考文献
1) 菊池真大. 肝疾患診療のためのスクリーニング検査. 総合健診 2016 ; 43 : 611-4.
 
2) 岡上武, 水野雅之. 肝機能検査, 肝障害について-健診における問題点. 総合健診 2015 ; 42 : 307-12.
 
3) 金井泉, 金井正光. 臨床検査法提要. 改訂34版. 東京 : 金原出版 ; 2015. p.35-7.
 
4) 垰田直美, ほか, 過ヨウ素酸ナトリウムを用いた血中ICG検査法の自動分析への試み. 日本臨床検査自動化学会会誌 2016 ; 41 : 270-7.
 
5) 幕内雅敏, ほか. 肝硬変合併肝癌治療のStrategy. 外科診療 1987 ; 29 : 1530-6.
 
6) 岩橋衆一, ほか. 肝硬変の肝予備能評価. 肝胆膵 2016 ; 73 : 1038-43.
 
7) 長谷川大輔, ほか. 99mTc-GSAシンチグラフィにおける肝予備能推定のための新しい定量指標算出の試み. 日本放射線技術学会雑誌 2016 ; 72 : 121-7.
 
8) Sawamura T, et al. Decrease of a hepatic binding protein specific for asialoglycoproteins with accumulation of serum asialoglycoproteins in galactosamine-treated rats. Gastroenterology 1981 ; 81 : 527-33.
PubMed
9) Sawamura T, et al. Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma. Asialoglycoprotein receptor in cirrhosis and liver cell carcinoma. Gastroenterology 1984 ; 87 : 1217-21.
PubMed
10) 鳥塚莞爾, ほか. 新しい肝機能イメージング剤99mTc-GSAの第2相臨床試験. 核医学 1992 ; 29 : 85-95.
 
11) 鳥塚莞爾, ほか. 新しい肝機能イメージング剤99mTc-GSAの第3相臨床試験-多施設による検討. 核医学 1992 ; 29 : 159-81.
 
12) Taniguchi M, et al. Hepatic clearance measured with (99m) Tc-GSA single-photon emission computed tomography to estimate liver fibrosis. World J Gastroenterol 2014 ; 20 : 16714-20.
PubMed
13) Kaibori M, et al. Usefulness of Tc-99m-GSA scintigraphy for liver surgery. Ann Nucl Med 2011 ; 25 : 593-602.
PubMed
14) Utsunomiya T, et al. Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve. J Gastroenterol 2012 ; 47 : 470-6.
PubMed
15) Nakagawa M, et al. Measuring hepatic functional reserve using T1 mapping of Gd-EOB-DTPA enhanced 3T MR imaging : A preliminary study comparing with (99m) Tc GSA scintigraphy and signal intensity based parameters. Eur J Radiol 2017 ; 92 : 116-23.
PubMed
16) Sumiyoshi T, et al. CT/99mTc-GSA SPECT fusion images demonstrate functional differences between the liver lobes. World J Gastroenterol 2013 ; 19 : 3217-2.
 
17) Child CG, Turcotte JG. Surgery and portal hypertension. In : Child CG. The Liver and Portal Hypertension. Philadelphia : Saunders ; 1964. p.50-64.
 
18) Pugh RN, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973 ; 60 : 646-9.
PubMed
19) 日本肝癌研究会, 編. 臨床・病理 原発性肝癌取扱い規約. 第6版. 東京 : 金原出版 ; 2015.
 
20) Kamath PS, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001 ; 33 : 464-70.
 
21) 巌康仁, ほか. 肝機能障害. 臨床外科 2017 ; 72 : 150-6.
 
22) Teh SH, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 2007 ; 132 : 1261-9.
PubMed
23) Sarin SK, et al ; APASL ACLF Working Party. Acute-on-chronic liver failure : Consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014. Hepatol Int 2014 ; 8 : 453-71.
 
24) Moreau R, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013 ; 144 : 1426-37.
PubMed
25) 持田智, ほか. 我が国における「急性肝不全」の概念, 診断基準の確立-厚生労働省科学研究費補助金 (難治性疾患克服研究事業) 「難治性の肝・胆道疾患に関する調査研究」班, ワーキンググループ-1, 研究報告. 肝臓 2011 ; 52 : 393-8.
 
26) 持田智. 劇症肝炎に関する研究. 厚生労働省科学研究費補助金 (難治性疾患克服研究事業) 「難治性の肝・胆道疾患に関する調査研究」班, 平成23-25年度総合報告書. 2014. p.29-44.
 
27) 杉原潤一, ほか. わが国における劇症肝炎の予後予測と肝移植の適応に関する多施設研究. 肝臓 2001 ; 42 : 543-57.
 
28) 市田隆文. 脳死肝移植レシピエント適応評価基準, 登録基準の変更. 消化器・肝臓内科 2017 ; 1 : 514-9.
 
29) 内木隆文, ほか. 劇症肝炎における新たな肝移植ガイドライン作成の試み. 日腹部救急医会誌 2009 ; 29 : 617-22.
 
30) 中山伸朗, 持田智. 肝移植適応ガイドラインの改変-高精度の予後予測システムの開発. 日消誌 2015 ; 112 : 840-7.
 
31) 滝川康裕, 片岡晃二郎. 急性肝障害の劇症化 (昏睡発現) 予知. 日消誌 2015 ; 112 : 822-8.
 
P.61 掲載の参考文献
1) Bernal W, Wendon J. Acute liver failure. N Engl J Med 2013 ; 369 : 2525-34.
PubMed
2) Sugawara K, et al. Acute liver failure in Japan : Definition, classification, and prediction of the outcome. J Gastroenterol 2012 ; 47 : 849-61.
PubMed
3) Bernal W, et al. Acute-on-chronic liver failure. Lancet 2015 ; 386 : 1576-87.
PubMed
4) Lee WM. Recent developments in acute liver failure. Best Pract Res Clin Gastroenterol 2012 ; 26 : 3-16.
PubMed
5) Shinozaki K, et al. Blood purification in fulminant hepatic failure. Contrib Nephrol 2010 ; 166 : 64-72.
PubMed
6) Haffar S, et al. Frequency and prognosis of acute pancreatitis associated with fulminant or non-fulminant acute hepatitis A : A systematic review. Pancreatology 2017 ; 17 : 166-175.
 
7) Chughlay MF, et al. N-acetylcysteine for non-paracetamol drug-induced liver injury : A systematic review. Br J Clin Pharmacol 2016 ; 81 : 1021-9.
PubMed
8) Liberal R, et al. Autoimmune hepatitis : From mechanisms to therapy. Rev Clin Esp 2016 ; 216 : 372-83.
PubMed
9) Lee WM. Recent developments in acute liver failure. Best Pract Res Clin Gastroenterol 2012 ; 26 : 3-16.
PubMed
10) Wree A, et al. Steroid and ursodesoxycholic Acid combination therapy in severe drug-induced liver injury. Digestion 2011 ; 84 : 54-9.
PubMed
11) Rama Rao KV, et al. Brain edema in acute liver failure : Mechanisms and concepts. Metab Brain Dis 2014 ; 29 : 927-36.
PubMed
12) Murphy N, et al. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004 ; 39 : 464-70.
PubMed
13) Jiang W, et al. Minocycline attenuates oxidative/nitrosative stress and cerebral complications of acute liver failure in rats. Neurochem Int 2009 ; 55 : 601-5.
PubMed
14) Kosenko E, et al. Blocking NMDA receptors prevents the oxidative stress induced by acute ammonia intoxication. Free Radic Biol Med 1999 ; 26 : 1369-74.
PubMed
15) Lee KC, et al. A reproducible, clinically relevant, intensively managed, pig model of acute liver failure for testing of therapies aimed to prolong survival. Liver Int 2013 ; 33 : 544-51.
PubMed
16) Manakkat Vijay GK, et al. Neutrophil toll-like receptor 9 expression and the systemic inflammatory response in acetaminophen-induced acute liver failure. Crit Care Med 2016 ; 44 : 43-53.
PubMed
17) Shawcross DL, Wendon JA. The neurological manifestations of acute liver failure. Neurochem Int 2012 ; 60 : 662-71.
PubMed
18) Ilyas JA, Kanwal F. Primary prophylaxis of variceal bleeding. Gastroenterol Clin North Am 2014 ; 43 : 783-94.
PubMed
19) Scott TR, et al. Pathophysiology of cerebral oedema in acute liver failure. World J Gastroenterol 2013 ; 19 : 9240-55.
 
20) Kiser TH, et al. Treatment of hepatorenal syndrome. Pharmacotherapy 2009 ; 29 : 1196-211.
PubMed
P.67 掲載の参考文献
1) Inoue K, et al. Japanese-style intensive medical care improves prognosis for acute liver failure and the perioperative management of liver transplantation. Transplant Proc 2010 ; 42 : 4109-12.
PubMed
2) Yoshiba M, et al. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artif Organs 1996 ; 20 : 1169-72.
PubMed
3) Inoue K, et al. Plasma exchange in combination with online-hemodiafiltration as a promising method for purifying the blood of fulminant hepatitis patients. Hepatol Res 2008 ; 38 : S46-51.
PubMed
4) Opolon P. High-permeability membrane hemodialysis and hemofiltration in acute hepatic coma : Experimental and clinical results. Artif Organs 1979 ; 3 : 354-60.
PubMed
5) 松田兼一, ほか. 劇症肝炎と急性肝不全. 一般社団法人日本アフェレシス学会, 編. アフェレシスマニュアル改訂第3版. 東京 : 学研メディカル秀潤社 ; 2010. p.200-8.
 
6) 平澤博之, ほか. 人工肝補助療法の現状と将来の展望-治療. 肝胆膵 2001 ; 42 : 485-95.
 
7) 今泉均, ほか. 急性肝不全に対する持続的血漿交換 (CPE) の意義. 集中治療 1997 ; 7 : 735-42.
 
8) 荒田慎寿, ほか. 急性肝不全に対するon-line hemodaifiltrationを用いた人工肝補助療法の確立. 肝臓 2012 ; 53 : 7-17.
 
9) 藤原慶一, ほか (厚生労働科学研究費補助金 難治性疾患克服研究事業「難治性の肝・胆道疾患に関する調査研究」班 劇症肝炎分科会 血液浄化法の有効性評価を目的としたワーキンググループ). 急性肝不全に対する人工肝補助療法についての提言-high-flow CHDF, on-line HDFによる覚醒率向上の認識とその全国標準化の必要性. 肝臓 2014 ; 55 : 79-81.
 
P.77 掲載の参考文献
1) 日本肝移植研究会. 肝移植症例登録報告. 移植 2016 ; 51 : 145-59.
 
2) 日本臓器移植ネットワーク. http://www.jotnw.or.jp/datafile/index.html
 
3) 日本臓器移植ネットワーク. 移植施設一覧 (2017年06月02日現在). https://www.jotnw.or.jp/jotnw/facilities/04.html
 
4) 市田隆文, ほか. わが国における脳死肝移植医療の現状と問題点. 肝臓 2015 ; 56 : 79-87.
 
5) 日本移植学会. 臓器移植ファクトブック 2016. http://www.asas.or.jp/jst/pro/pro8.html
 
6) 持田智. 劇症肝炎に関する研究. 厚生労働省科学研究費補助金 (難治性疾患克服研究事業) 「難治性の肝・胆道疾患に関する調査研究」班. 平成23-25年度総合報告書. 2014. p.29-44.
 
7) 江川裕人, ほか. Rituximab投与ABO血液型不適合生体肝移植における安全性と有効性に関する後方視的調査研究. 移植 2015 ; 50 : 62-77.
 
8) Tanabe M, et al. Intra-portal infusion therapy as a novel approach to adult ABO incompatible liver transplantation. Transplantation 2002 ; 73 : 1959-61.
 
9) Monteiro I, et al. Rituximab with plasmapheresis and splenectomy in abo-incompatible liver transplantation. Transplantation 2003 ; 76 : 1648-9.
PubMed
10) Kawagishi N, et al. New strategy for ABO-incompatible living donor liver transplantation with anti-CD20 antibody (rituximab) and plasma exchange. Transplant Proc 2005 ; 37 : 1205-6.
PubMed
11) Tanabe M, et al. Current progress in ABO-incompatible liver transplantation. Eur J Clin Invest 2010 ; 40 : 943-9.
PubMed
12) 金守良. 韓国における脳死肝移植の現状. 肝臓 2017 ; 58 : 310-8.
 
13) International Registry in Organ Donation and Transplantation (IRODaT). Worldwide Actual Deceased Donors (PMP). 2013. http://www.irodat.org/?p=database
 
14) 市田隆文. 脳死肝移植レシピエント適応評価基準, 登録基準の変更. 消化器・肝臓内科 2017 ; 1 : 514-9.
 

[ 急性腎傷害 ]

P.90 掲載の参考文献
1) 福井次矢, 黒川清, 日本語版監修. ハリソン内科学. 第2版. 東京 : メディカル・サイエンス・インターナショナル. 2006. p.1696.
 
2) Kellum JA, et al. Developing a consensus classification system for acute renal failure. Curr Opin Crit Care 2002 ; 8 : 509-14.
PubMed
3) Kellum JA, et al. Kidney attack. JAMA 2012 ; 307 : 2265-6.
PubMed
4) Bellomo R, et al ; Acute Dialysis Quality Initiative workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs : The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004 ; 8 : R204-12.
PubMed
5) National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease : Evaluation, classification, and stratification. Am J Kidney Dis 2002 ; 39 : S1-266.
PubMed
6) Uchino S, et al. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006 ; 34 : 1913-7.
PubMed
7) Hoste EA, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients : A cohort analysis. Crit Care 2006 ; 10 : R73.
PubMed
8) Bagshaw SM, et al. A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008 ; 23 : 1203-10.
PubMed
9) Chao CT, et al. Advanced age affects the outcome-predictive power of RIFLE classification in geriatric patients with acute kidney injury. Kidney Int 2012 ; 82 : 920-7.
PubMed
10) Ricci Z, et al. The RIFLE criteria and mortality in acute kidney injury : A systematic review. Kidney Int 2008 ; 73 : 538-46.
PubMed
11) Bouchard J, et al. Comparison of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury. Nephrol Dial Transplant 2010 ; 25 : 102-7.
PubMed
12) Englberger L, et al. RIFLE is not RIFLE : On the comparability of results. Crit Care 2009 ; 13 : 429.
 
13) Pickering JW, et al. GFR shot by RIFLE : Errors in staging acute kidney injury. Lancet 2009 ; 373 (9672) : 1318-9.
PubMed
14) Cruz DN, et al. Clinical review : RIFLE and AKIN--time for reappraisal. Crit Care 2009 ; 13 : 211.
PubMed
15) Maccariello E, et al. RIFLE classification in patients with acute kidney injury in need of renal replacement therapy. Intensive Care Med 2007 ; 33 : 597-605.
PubMed
16) Mehta RL, et al. Acute Kidney Injury Network : Report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007 ; 11 : R31.
PubMed
17) Lassnigg A, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery : A prospective cohort study. J Am Soc Nephrol 2004 ; 15 : 1597-605.
PubMed
18) Ostermann M, et al. Correlation between the AKI classification and outcome. Crit Care 2008 ; 12 : R144.
PubMed
19) Mandelbaum T, et al. Outcome of critically ill patients with acute kidney injury using the Acute Kidney Injury Network criteria. Crit Care Med 2011 ; 39 : 2659-64.
PubMed
20) Lopes JA, et al. Acute kidney injury in intensive care unit patients : A comparison between the RIFLE and the Acute Kidney Injury Network classifications. Crit Care 2008 ; 12 : R110.
PubMed
21) Bagshaw SM, et al ; ANZICS Database Management Committee. A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008 ; 23 : 1569-74.
 
22) Joannidis M, et al. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med 2009 ; 35 : 1692-702.
PubMed
23) Lopes JA, Jorge S. The RIFLE and AKIN classifications for acute kidney injury : A critical and comprehensive review. Clin Kidney J 2013 ; 6 : 8-14.
PubMed
24) Kidney Disease : Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012 ; 2 : 1-138.
 
25) Zeng X, et al. Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol 2014 ; 9 : 12-20.
PubMed
26) Luo X, et al. A comparison of different diagnostic criteria of acute kidney injury in critically ill patients. Crit Care 2014 ; 18 : R144.
 
27) Prowle JR, et al. Serum creatinine changes associated with critical illness and detection of persistent renal dysfunction after AKI. Clin J Am Soc Nephrol 2014 ; 9 : 1015-23.
PubMed
28) Waikar SS, et al. Creatinine as the gold standard for kidney injury biomarker studies? Nephrol Dial Transplant 2009 ; 24 : 3263-65.
PubMed
29) Liu KD, et al. ; National Institutes of Health National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network. Acute kidney injury in patients with acute lung injury : Impact of fluid accumulation on classification of acute kidney injury and associated outcomes. Crit Care Med 2011 ; 39 : 2665-71.
PubMed
30) Moore E, et al. The impact of fluid balance on the detection, classification and outcome of acute kidney injury after cardiac surgery. J Cardiothorac Vasc Anesth 2015 ; 29 : 1229-35.
PubMed
31) National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006 ; 354 : 2564-75.
PubMed
32) Teixeira C, et al. Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care 2013 ; 17 : R14.
PubMed
33) Wlodzimirow KA, et al. A comparison of RIFLE with and without urine output criteria for acute kidney injury in critically ill patients. Crit Care 2012 ; 16 : R200.
PubMed
34) Han SS, et al. Additional role of urine output criterion in defining acute kidney injury. Nephrol Dial Transplant 2012 ; 27 : 161-5.
PubMed
35) Kellum JA, et al. Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol 2015 ; 26 : 2231-8.
 
36) Engoren M, et al. The association between urine output, creatinine elevation, and death. Ann Thorac Surg 2017 ; 103 : 1229-37.
PubMed
37) Md Ralib A, et al. The urine output definition of acute kidney injury is too liberal. Crit Care 2013 ; 17 : R112.
PubMed
38) Ronco C, et al. Subclinical AKI is still AKI. Crit Care 2012 ; 16 : 313.
PubMed
39) Chawla LS, et al. Renal angina : Concept and development of pretest probability assessment in acute kidney injury. Crit Care 2015 ; 19 : 93.
 
40) AKI (急性腎障害) 診療ガイドライン作成委員会, 編. AKI (急性腎障害) 診療ガイドライン 2016. 東京 : 東京医学社 ; 2016.
 
P.103 掲載の参考文献
1) Hilton R. Acute renal failure. BMJ 2006 ; 333 : 786-90.
PubMed
2) Makris K, Spanou L. Acute kidney injury : Definition, pathophysiology and clinical phenotypes. Clin Biochem Rev 2016 ; 37 : 85-98.
PubMed
3) Uchino S, et al. Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol Dial Transplant 2010 ; 25 : 1833-9.
PubMed
4) Doi K. Role of kidney injury in sepsis. J Intensive Care 2016 ; 4 : 17.
PubMed
5) Post EH, et al. Renal perfusion in sepsis : From macro-to microcirculation. Kidney Int 2017 ; 91 : 45-60.
PubMed
6) Bellomo R, et al. Acute kidney injury in sepsis. Intensive Care Med 2017 ; 43 : 816-28.
PubMed
7) Mao H, et al. Cardiac surgery-associated acute kidney injury. Blood Purif 2014 ; 37 (Suppl 2) : 34-50.
 
8) O'Neal JB, et al. Acute kidney injury following cardiac surgery : Current understanding and future directions. Crit Care 2016 ; 20 : 187.
PubMed
9) Romagnoli S, et al. Postoperative acute kidney injury in high-risk patients undergoing major abdominal surgery. J Crit Care 2016 ; 35 : 120-5.
PubMed
10) Schmid S, et al. Algorithm-guided goal-directed haemodynamic therapy does not improve renal function after major abdominal surgery compared to good standard clinical care : A prospective randomised trial. Crit Care 2016 ; 20 : 50.
PubMed
11) Thadhani R, et al. Acute renal failure. N Engl J Med 1996 ; 334 : 1448-60.
PubMed
12) Sinha Ray A, et al. Vancomycin and the risk of AKI : A systematic review and meta-analysis. Clin J Am Soc Nephrol 2016 ; 11 : 2132-40.
 
13) Nochaiwong S, et al. The association between proton pump inhibitor use and the risk of adverse kidney outcomes : A systematic review and meta-analysis. Nephrol Dial Transplant 2017 Feb 23. doi : 10.1093/ndt/gfw470.
 
14) McCullough PA, et al. Contrast-induced acute kidney injury. J Am Coll Cardiol 2016 ; 68 : 1465-73.
PubMed
15) McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008 ; 51 : 1419-28.
PubMed
16) Mehran R, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention : Development and initial validation. J Am Coll Cardiol 2004 ; 44 : 1393-9.
PubMed
17) Fahling M, et al. Understanding and preventing contrast-induced acute kidney injury. Nat Rev Nephrol 2017 ; 13 : 169-80.
PubMed
18) Leoncini M, et al. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome : Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome). J Am Coll Cardiol 2014 ; 63 : 71-9.
 
19) Chavez LO, et al. Beyond muscle destruction : A systematic review of rhabdomyolysis for clinical practice. Crit Care 2016 ; 20 : 135.
PubMed
20) Bosch X, et al. Rhabdomyolysis and acute kidney injury. N Engl J Med 2009 ; 361 : 62-72.
PubMed
21) Campbell GA, et al. Acute kidney injury in the cancer patient. Adv Chronic Kidney Dis 2014 ; 21 : 64-71.
PubMed
P.111 掲載の参考文献
1) Bellomo R, et al ; ADQI workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs : The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004 ; 8 : R204-12.
PubMed
2) Mehta RL, et al ; Acute Kidney Injury Network. Acute Kidney Injury Network : Report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007 ; 11 : R31.
PubMed
3) Kellum JA, et al ; Kidney disease : Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney International Supplements 2012 ; 2 : 1-138.
 
4) Mori K, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005 ; 115 : 610-21.
PubMed
5) Mishra J, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005 ; 365 : 1231-8.
PubMed
6) Portilla D, et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int 2008 ; 73 : 465-72.
PubMed
7) Han WK, et al. Kidney Injury Molecule-1 (KIM-1) : A novel biomarker for human renal proximal tubule injury. Kidney Int 2002 ; 62 : 237-44.
PubMed
8) AKI (急性腎障害) 診療ガイドライン作成委員会, 編. AKI (急性腎障害) 診療ガイドライン 2016. 東京 : 東京医学社 ; 2016.
 
9) McCullough PA, et al. Diagnosis of acute kidney injury using functional and injury biomarkers : Workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol 2013 ; 182 : 13-29.
PubMed
10) Flower DR, et al. The lipocalin protein family : Structural and sequence overview. Biochim Biophys Acta 2000 ; 1482 : 9-24.
PubMed
11) Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int 2007 ; 71 : 967-70.
PubMed
12) Przybylowski P, et al. Liver fatty-acid-binding protein in heart and kidney allograft recipients in relation to kidney function. Transplant Proc 2011 ; 43 : 3064-7.
PubMed
13) 森潔, ほか. siderophore 結合蛋白の生物学-分化誘導, 組織障害, 癌, 感染, 造血の新しい接点. 臨床血液 2009 ; 50 ; 519-26.
 
14) 森潔, ほか. Ngal の病態生理的意義. 富野康日己, 編. Annual Review腎臓. 東京 : 中外医学社 ; 2013. p.143-9.
 
15) Goetz DH, et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 2002 ; 10 : 1033-43.
PubMed
16) Kamijo-Ikemori A, et al. Urinary fatty acid binding protein in renal disease. Clin Chim Acta 2006 ; 374 : 1-7.
PubMed
17) Devarajan P. Review : Neutrophil gelatinase-associated lipocalin : A troponin-like biomarker for human acute kidney injury. Nephrology 2010 ; 15 : 419-28.
PubMed
18) Hayashi H, et al. Efficacy of urinary midkine as a biomarker in patients with acute kidney injury. Clin Exp Nephrol 2017 ; 21 : 597-607.
PubMed
19) Kasuno K, et al. Renal redox dysregulation in AKI : Application for oxidative stress marker of AKI. Am J Physiol Renal Physiol 2014 ; 307 : F1342-51.
PubMed
20) 高橋駿介, ほか. 急性腎障害における新たな尿中バイオマーカー-アクチビン. 日腎会誌 2017 ; 59 : 264.
 
21) Kjeldsen L, et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993 ; 268 ; 10425-32.
PubMed
22) Yan L, et al. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 2001 ; 276 : 37258-65.
PubMed
23) Martensson J, et al. Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 2010 ; 36 : 1333-40.
PubMed
24) Kanda J, et al. An AKI biomarker lipocalin 2 in the blood derives from the kidney in renal injury but from neutrophils in normal and infected conditions. Clin Exp Nephrol 2015 ; 19 : 99-106.
 
25) Paragas N, et al. alpha-Intercalated cells defend the urinary system from bacterial infection. J Clin Invest 2014 ; 124 : 2963-76.
PubMed
26) Yang J, et al. An iron delivery pathway mediated by a lipocalin. Mol Cell 2002 ; 10 : 1045-56.
 
27) Flo TH, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004 ; 432 ; 917-21.
PubMed
28) Kuwabara T, et al. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int 2009 ; 75 : 285-94.
PubMed
29) Paragas N, et al. The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med 2011 ; 17 : 216-22.
PubMed
30) Kamijo A, et al. Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am J Pathol 2004 ; 165 : 1243-55.
PubMed
31) Yamamoto T, et al. Renal L-type fatty acid--Binding protein in acute ischemic injury. J Am Soc Nephrol 2007 ; 18 : 2894-902.
PubMed
32) Nickolas TL, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008 ; 148 : 810-9.
PubMed
33) Doi K, et al. Mild elevation of urinary biomarkers in prerenal acute kidney injury. Kidney Int 2012 ; 82 : 1114-20.
PubMed
34) Asada T, et al. Impact of clinical context on acute kidney injury biomarker performances : Differences between neutrophil gelatinase-associated lipocalin and L-type fatty acid-binding protein. Sci Rep 2016 ; 6 : 33077.
PubMed
35) Wagener G, et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006 ; 105 : 485-91.
PubMed
36) Kasahara M, et al. Reduction in urinary excretion of neutrophil gelatinase-associated lipocalin by angiotensin receptor blockers in hypertensive patients. Nephrol Dial Transplant 2009 ; 24 : 2608-9 ; author reply 2609-10.
 
37) Bolignano D, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin j Am Soc Nephrol 2009 ; 4 : 337-44.
PubMed
38) Kamijo A, et al. Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med 2004 ; 143 : 23-30.
PubMed
39) Kamijo-Ikemori A, et al. Urinary liver type fatty acid binding protein in diabetic nephropathy. Clin Chim Acta 2013 ; 424 : 104-8.
PubMed
40) Nakamura T, et al. Urinary liver-type fatty acid-binding protein in septic shock : Effect of polymyxin B-immobilized fiber hemoperfusion. Shock 2009 ; 31 : 454-9.
PubMed
41) Katagiri D, et al. Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery. Ann Thorac Surg 2012 ; 93 : 577-83.
PubMed
42) Du Y, et al. Urinary biomarkers to detect acute kidney injury in the pediatric emergency center. Pediatric Nephrol 2011 ; 26 : 267-74.
PubMed
43) Parikh CR, et al. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 2005 ; 16 : 3046-52.
PubMed
44) Parikh CR, et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006 ; 70 : 199-203.
PubMed
45) Ho J, et al. Urinary, plasma, and serum biomarkers' utility for predicting acute kidney injury associated with cardiac surgery in adults : A meta-analysis. Am J Kidney Dis 2015 ; 66 : 993-1005.
PubMed
46) Haase M, et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury : A systematic review and meta-analysis. Am J Kidney Dis 2009 ; 54 : 1012-24.
PubMed
47) Susantitaphong P, et al. Performance of urinary liver-type fatty acid-binding protein in acute kidney injury : A meta-analysis. Am J Kidney Dis 2013 ; 61 : 430-9.
PubMed
48) Nakada Y, et al. Prognostic value of urinary neutrophil gelatinase-associated lipocalin on the first day of admission for adverse events in patients with acute decompensated heart failure. J Am Heart Assoc 2017 ; 6 (5). pii : e004582. doi : 10.1161/JAHA.116. 004582.
 
49) Zarbock A, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury : The ELAIN Randomized Clinical Trial. JAMA 2016 ; 315 : 2190-9.
PubMed
50) McIlroy DR, et al. Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery : The effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol 2010 ; 5 : 211-9.
PubMed
51) Succar L, et al. Subclinical chronic kidney disease modifies the diagnosis of experimental acute kidney injury. Kidney Int 2017 ; 92 : 680-92.
PubMed
52) Capuano F, et al. Neutrophil gelatinase-associated lipocalin levels after use of mini-cardiopulmonary bypass system. Interact Cardiovasc Thorac Surg 2009 ; 9 : 797-801.
PubMed
53) Meersch M, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers : The PrevAKI randomized controlled trial. Intensive Care Med 2017. doi : 10.1007/s00134-016-4670-3.
 
54) Kashani K, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013 ; 17 : R25.
PubMed
55) Endre ZH, Pickering JW. Acute kidney injury : Cell cycle arrest biomarkers win race for AKI diagnosis. Nat Rev Nephrol 2014 ; 10 : 683-5.
PubMed
P.127 掲載の参考文献
1) AKI (急性腎障害) 診療ガイドライン作成委員会, 編. AKI (急性腎障害) 診療ガイドライン 2016. 東京 : 東京医学社 ; 2016.
 
2) Bellomo R, et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs : The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004 ; 8 : R204-12.
PubMed
3) Mehta RL, et al. Acute Kidney Injury Network : Report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007 ; 11 : R31.
PubMed
4) Kidney Disease : Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012 ; 2 : 1-138.
 
5) Jetton JG, Askenazi DJ. Acute kidney injury in the neonate. Clin Perinatol 2014 ; 41 : 487-502.
PubMed
6) Selewski DT, et al. Neonatal Acute Kidney Injury. Pediatrics 2015 ; 136 : e463-73.
PubMed
7) Mehran R, et al. A simple risk score for prediction of contrastinduced nephropathy after percutaneous coronary intervention : Development and initial validation. J Am Coll Cardiol 2004 ; 44 : 1393-9.
PubMed
P.141 掲載の参考文献
1) 平澤博之. 重症敗血症/敗血症性ショックの今日的病態生理と持続的血液濾過透析 (CHDF) によるその制御. 日救急医会誌 2011 ; 22 : 85-116.
 
2) 森山和広, 西田修. 敗血症に対する急性血液浄化法 (濾過・透析・吸着) の新たなる展開とは? 救急・集中治療 2017 ; 29 : 431-8.
 
3) 西田修, ほか. HMGB1制御のためのアフェレシス. 日アフェレシス会誌 2012 ; 31 : 148-55.
 
4) Yumoto M, et al. In vitro evaluation of high mobility group box 1 protein removal with various membranes for continuous hemofiltration. Ther Apher Dial 2011 ; 15 : 385-93.
PubMed
5) Shiga H, et al. Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock : A preliminary report. Blood Purif 2014 ; 38 : 211-8.
PubMed
6) 西田修, ほか. 日本版敗血症診療ガイドライン 2016. CQ12 : 急性腎障害・血液浄化法. 日集中医誌 2016 ; 24 (Suppl 2) : S130-45.
 
7) AKI (急性腎障害) 診療ガイドライン作成委員会, 編. AKI (急性腎障害) 診療ガイドライン 2016. 東京 : 東京医学社 ; 2016. p.54-69.
 
8) 西田修, ほか. 急性血液浄化療法施行時の抗菌薬投与の基本的な考え方. ICUとCCU 2013 ; 37 : 929-37.
 
9) 山下千鶴, ほか. 腎不全, 血液浄化施行時の抗菌薬治療. レジデントノート 2015 ; 8 : 108-15.
 
10) 中村智之, 西田修. 急性血液浄化中の栄養療法. 日静脈経腸栄会誌 2016 ; 31 : 821-6.
 
11) Kidney Disease : Improving global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012 ; 2 : 1-138.
 
12) 日本集中治療医学会重症患者の栄養管理ガイドライン作成委員会 ; 小谷穣治, ほか. 日本版重症患者の栄養療法ガイドライン. 日集中医誌 2016 ; 23 : 185-281.
 
P.150 掲載の参考文献
1) Kidney Disease : Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012 ; 2 : 1-138.
 
2) AKI (急性腎障害) 診療ガイドライン作成委員会, 編. AKI (急性腎障害) 診療ガイドライン 2016. 東京 : 東京医学社 ; 2016.
 
3) Fayad AI, et al. Timing of continuous renal replacement therapy initiation for acute kidney injury. Cochrane Database of Systematic Reviews 2013 ; Issue 6. Art. No. : CD010612.
 
4) Karvellas CJ, et al. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury : A systematic review and meta-analysis. Crit Care 2011 ; 15 : R72.
PubMed
5) Bagshaw SM, et al. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care 2009 ; 24 : 129-40.
PubMed
6) Uchino S, et al. Acute renal failure in critically ill patients : A multinational, multicenter study. JAMA 2005 ; 294 : 813-8.
PubMed
7) Wald R, et al. Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury. Kidney Int 2015 ; 88 : 897-904.
PubMed
8) Zarbock A, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury : The ELAIN randomized clinical trial. JAMA 2016 ; 315 : 2190-9.
PubMed
9) Gaudry S, et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 2016 ; 375 : 122-33.
PubMed
10) Smith OM, et al. Standard versus accelerated initiation of renal replacement therapy in acute kidney injury (STARRT-AKI) : Study protocol for a randomized controlled trial. Trials 2013 ; 14 : 320.
PubMed
11) Lai TS, et al. Earlier versus later initiation of renal replacement therapy among critically ill patients with acute kidney injury : A systematic review and meta-analysis of randomized controlled trials. Ann Intensive Care 2017 ; 7 : 38.
PubMed
12) Aniort J, et al. Daily urinary urea excretion to guide intermittent hemodialysis weaning in critically ill patients. Crit Care 2016 ; 20 : 43.
PubMed
13) Viallet N, et al. Daily urinary creatinine predicts the weaning of renal replacement therapy in ICU acute kidney injury patients. Ann Intensive Care 2016 ; 6 : 71.
PubMed
14) Uchino S, et al. Discontinuation of continuous renal replacement therapy : A post hoc analysis of a prospective multicenter observational study. Crit Care Med 2009 ; 37 : 2576-82.
PubMed
15) Wu VC, et al. Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy. Intensive Care Med 2008 ; 34 : 101-8.
PubMed
16) van der Voort PH, et al. Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients : A double blind randomized controlled trial. Crit Care Med 2009 ; 37 : 533-8.
PubMed
17) Barbar SD, et al. Impact on mortality of the timing of renal replacement therapy in patients with severe acute kidney injury in septic shock : The IDEAL-ICU study (initiation of dialysis early versus delayed in the intensive care unit) : Study protocol for a randomized controlled trial. Trials 2014 ; 15 : 270.
PubMed
P.159 掲載の参考文献
1) Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V : An analysis of error. J Am Soc Nephrol 1993 ; 4 : 1205-13.
 
2) 鈴木一之, ほか. 血液透析条件・透析量と生命予後-日本透析医学会の統計調査結果から. 透析会誌 2010 ; 43 : 551-9.
 
3) Eknoyan G, Levin N. NKF-K/DOQI Clinical Practice Guidelines : Update 2000. Foreword. Am J Kidney Dis 2001 ; 37 : S5-6.
PubMed
4) 日本透析医学会維持血液透析療法ガイドライン作成ワーキンググループ, 編. 維持血液透析ガイドライン-血液透析処方. 透析会誌 2013 ; 46 : 587-632.
 
5) Nissenson A, Rastogi A. Renal replacement therapy in the intensive care unit. In : Ronco C, et al, eds. Critical Care Nephrology. 2 nd Edition. Philadelphia, PA : Saunders Elsevier ; 2009. p. 1125-8.
 
6) Ronco C, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure : A prospective randomised trial. Lancet 2000 ; 356 : 26-30.
PubMed
7) Sauden P, et al. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 2006 ; 70 : 1312-7.
 
8) Bouman CS, et al. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure : A prospective, randomized trial. Crit Care Med 2002 ; 30 : 2205-11.
PubMed
9) Tolwani AJ, et al. Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol 2008 ; 19 : 1233-8.
 
10) The VA/NIH Acute Renal Failure Trial Network, Palevsky PM, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008 ; 359 : 7-20.
PubMed
11) The RENAL Replacement Therapy Study Investigators, Bellomo R, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009 ; 361 : 1627-38.
 
12) Kellum JA, Ronco C. Results of RENAL--what is the optimal CRRT target dose? Nat Rev Nephrol 2010 ; 6 : 191-2.
PubMed
13) Prowle JR, et al. Clinical review : Optimal dose of continuous renal replacement therapy in acute kidney injury. Crit Care 2011 ; 15 : 207.
PubMed
14) Vesconi S, et al. Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care 2009 ; 13 : R57.
PubMed
15) The Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Working Group ; Kellum JA, et al. Dialysis interventions for treatment of AKI. Kidney Int Suppl 2012 ; 2 : 89-115.
 
16) Faulhaber-Walter R, et al. The Hannover Dialysis Outcome study : Comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit. Nephrol Dial Transplant 2009 ; 24 : 2179-86.
PubMed
17) Joannes-Boyau O, et al. High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study) : A multicentre randomized controlled trial. Intensive Care Med 2013 ; 39 : 1535-46.
PubMed
18) Fayad AI, et al. Intensity of continuous renal replacement therapy for acute kidney injury. Cochrane Database Syst Rev 2016 ; 10 : CD010613.
PubMed
19) Fujii T, et al. Low-dose continuous renal replacement therapy for acute kidney injury. Int J Artif Organs 2012 ; 35 : 525-30.
PubMed
20) Uchino S, et al. Validity of low-intensity continuous renal replacement therapy. Crit Care Med 2013 ; 41 : 2584-91.
PubMed
21) Yasuda H, et al ; Japanese Society for Physicians and Trainees in Intensive Care (JSEPTIC) Clinical Trial Group. The lower limit of intensity to control uremia during continuous renal replacement therapy. Crit Care 2014 ; 18 : 539.
 
P.168 掲載の参考文献
1) Shiga H, et al. Continuous hemodiafiltration in pediatric critical care patients. Ther Apher Dial 2004 ; 8 : 390-7.
PubMed
2) Schaefer F, et al. Dialysis in neonates with inborn errors of metabolism. Nephrol Dial Transplant 1999 ; 14 : 910-8.
PubMed
3) Li PK, et al. ISPD peritonitis recommendations : 2016 update on prevention and treatment. Perit Dial Int 2016 ; 36 : 481-508.
PubMed
4) Radtke J, et al. Surgical complications after peritoneal dialysis catheter implantation depend on children's weight. J Pediatr Surg 2015 ; 51 : 1317-20.
 
伊藤秀一, 和田尚弘, 監修. 小児急性血液浄化療法ハンドブック. 東京 : 東京医学社 ; 2013.
 
東京都立小児総合医療センター腎臓内科, 編. 小児のCKD/AKI実践マニュアル-透析・移植まで. 東京 : 診断と治療社. 2013.
 
AKI (急性腎障害) 診療ガイドライン作成委員会, 編. AKI (急性腎障害) 診療ガイドライン 2016. 9章. 東京 : 東京医学社 ; 2016. p.72-85.
 
P.177 掲載の参考文献
1) Wischmeyer PE, San-Millan I. Winning the war against ICU-acquired weakness : New innovations in nutrition and exercise physiology. Crit Care 2015 ; 19 (Suppl 3) : S6.
 
2) 日本集中治療医学会重症患者の栄養管理ガイドライン作成委員会. 日本版重症患者の栄養療法ガイドライン. 日集中医誌 2016 ; 23 : 185-281.
 
3) McClave SA, et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient : Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 2016 ; 40 : 159-211.
 
4) Dvir D, et al. Computerized energy balance and complications in critically ill patients : An observational study. Clin Nutr 2006 ; 25 : 37-44.
PubMed
5) Ferrie S, et al. Protein requirements in the critically ill : A randomized controlled trial using parenteral nutrition. JPEN J Parenter Enteral Nutr 2016 ; 40 : 795-805.
PubMed
6) Cano N, et al. ESPEN Guidelines on Enteral Nutrition : Adult renal failure. Clin Nutr 2006 ; 25 : 295-310.
PubMed
7) McCarthy MS, et al. Special nutrition challenges : Current approach to acute kidney injury. Nutr Clin Pract 2014 ; 29 : 56-62.
PubMed
8) van den Berghe G, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001 ; 345 : 1359-67.
PubMed
9) NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009 ; 360 : 1283-97.
 
10) Inoue S, et al. Accuracy of blood-glucose measurements using glucose meters and arterial blood gas analyzers in critically ill adult patients : Systematic review. Crit Care 2013 ; 17 : R48.
PubMed
P.186 掲載の参考文献
1) Mehta RL, et al. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 2002 ; 288 : 2547-53.
PubMed
2) Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012 ; 2 : 1-138.
 
3) Bouchard J, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 2009 ; 76 : 422-7.
PubMed
4) Payen D, et al. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 2008 ; 12 : R74.
PubMed
5) Wiedemann HP, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006 ; 354 : 2564-75.
PubMed
6) Mikkelsen ME, et al. The adult respiratory distress syndrome cognitive outcomes study : Long-term neuropsychological function in survivors of acute lung injury. Am J Respir Crit Care Med 2012 ; 185 : 1307-15.
PubMed
7) Ho KM, Power BM. Benefits and risks of furosemide in acute kidney injury. Anaesthesia 2010 ; 65 : 283-93.
PubMed
8) Arai S, et al. Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice. Nat Med 2016 ; 22 : 183-93.
PubMed
9) Nakano D, et al. Reduction of tubular flow rate as a mechanism of oliguria in the early phase of endotoxemia revealed by intravital imaging. J Am Soc Nephrol 2015 ; 26 : 3035-44.
PubMed
10) Brater D, Voelker J. Use of diuretics in patients with renal disease. In : Bennett WM, McCarron DA, eds. Pharmacotherapy of Renal Disease and Hypertension. Contemporary Issues in Nephrology. Vol 17. New York : Churchill Livingstone ; 1987.
 
11) Chawla LS, et al. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care 2013 ; 17 : R207.
PubMed
12) Koyner JL, et al. Furosemide stress test and biomarkers for the prediction of AKI severity. J Am Soc Nephrol 2015 ; 26 : 2023-31.
PubMed
13) Mukoyama M, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991 ; 87 : 1402-12.
PubMed
14) Allgren RL, et al. Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 1997 ; 336 : 828-34.
 
15) Lewis J, et al. Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am J Kidney Dis 2000 ; 36 : 767-74.
 
16) Nigwekar SU, et al. Atrial natriuretic peptide for management of acute kidney injury : A systematic review and meta-analysis. Clin J Am Soc Nephrol 2009 ; 4 : 261-72.
PubMed
17) Nigwekar SU, et al. Atrial natriuretic peptide for preventing and treating acute kidney injury. Cochrane Database Syst Rev 2009 : CD006028.
PubMed
18) Zacharias M, et al. Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev 2013 : CD003590.
PubMed
P.194 掲載の参考文献
1) Goldberg LI, et al. Sodium diuresis produced by dopamine in patients with congestive heart failure. N Engl J Med 1963 ; 269 : 1060-4.
PubMed
2) Mcdonald RH Jr, et al. Effect of dopamine in man : Augmentation of sodium excretion, glomerular filtration rate, and renal plasma flow. J Clin Invest 1964 ; 43 : 1116-24.
PubMed
3) Bellomo R, et al. Low-dose dopamine in patients with early renal dysfunction : A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000 ; 356 (9248) : 2139-43.
 
4) De Backer D, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010 ; 362 : 779-89.
 
5) Zacharias M, et al. Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev 2013 ; (9) : CD003590.
PubMed
6) Richer M, et al. Renal hemodynamics during norepinephrine and low-dose dopamine infusions in man. Crit Care Med 1996 ; 24 : 1150-6.
PubMed
7) Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 2004 ; 351 : 159-69.
PubMed
8) Langenberg C, et al. Renal blood flow in experimental septic acute renal failure. Kidney Int 2006 ; 69 : 1996-2002.
PubMed
9) Di Giantomasso D, et al. Norepinephrine and vital organ blood flow during experimental hyperdynamic sepsis. Intensive Care Med 2003 ; 29 : 1774-81.
PubMed
10) Landry DW, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997 ; 95 : 1122-5.
 
11) Di Giantomasso D, et al. Effect of low-dose vasopressin infusion on vital organ blood flow in the conscious normal and septic sheep. Anaesth Intensive Care 2006 ; 34 : 427-33.
PubMed
12) Russell JA, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008 ; 358 : 877-87.
PubMed
13) Gordon AC, et al. The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med 2010 ; 36 : 83-91.
PubMed
14) Russell JA, et al. Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock. Am J Respir Crit Care Med 2013 ; 188 : 356-64.
PubMed
15) Gordon AC, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock : The VANISH randomized clinical trial. JAMA 2016 ; 316 : 509-18.
PubMed
16) Hajjar LA, et al. Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery : The VANCS randomized controlled trial. Anesthesiology 2017 ; 126 : 85-93.
PubMed
17) Edwards RM, et al. Renal microvascular effects of vasopressin and vasopressin antagonists. Am J Physiol 1989 ; 256 (2 Pt 2) : F274-8.
 
日本肝臓学会・日本医学放射線学会・日本循環器学会, 編. 腎障害患者におけるヨード造影剤使用に関するガイドライン 2012. 東京 : 東京医学社 ; 2012.
 
AKI (急性腎障害) 診療ガイドライン作成委員会, 編. AKI (急性腎障害) 診療ガイドライン 2016. 東京 : 東京医学社 ; 2016.
 
日本版敗血症診療ガイドライン 2016 (J-SSCG2016). http://www.jsicm.org/pdf/jjsicm24Suppl2-2.pdf
 
P.203 掲載の参考文献
1) Avner ED, et al, eds. Pediatric Nephrology. 7th ed. Berlin : Springer-Verlag ; 2015. p.2139-67.
 
2) Hui-Stickle S, et al. Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 2005 ; 45 : 96-101.
 
3) Duzova A, et al. Etiology and outcome of acute kidney injury in children. Pediatr Nephrol 2010 ; 25 : 1453-61.
PubMed
4) Flynn JT. Choice of dialysis modality for management of pediatric acute renal failure. Pediatr Nephrol 2002 ; 17 : 61-9.
PubMed
5) Symons JM, et al. Demographic characteristics of pediatric continuous renal replacement therapy : A report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol 2007 ; 2 : 732-8.
PubMed
6) 伊藤秀一, ほか. わが国の小児急性血液浄化療法の実態調査. 日本小児腎不全学会雑誌 2012 : 32 : 231-2.
 
7) Kaddourah A, et al. Epidemiology of acute kidney injury in critically ill children and young adults. N Engl J Med 2017 ; 376 : 11-20.
 
8) Kidney Disease : Improving Global Outcomes (KDIGO) Acute Kidney Injury word Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012 : 2 : 1-138.
 
9) AKI (急性腎障害) 診療ガイドライン作成委員会, 編. AKI (急性腎障害) 診療ガイドライン 2016. 東京 : 東京医学社 ; 2016.
 
10) Uemura O, et al. Age, gender, and body length effects on reference serum creatinine levels determined by an enzymatic method in Japanese children : A multicenter study. Clin Exp Nephrol 2011 ; 15 : 694-9.
PubMed
11) Dinkel E, et al. Kidney size in childhood. Sonographical growth charts for kidney length and volume. Pediatr Radiol 1985 ; 15 : 38-43.
PubMed
12) Nagasawa H, et al. Longitudinal observations of left ventricular end-diastolic dimension in children using echocardiography. Pediatr Cardiol 1996 ; 17 : 169-74.
PubMed
13) Filho LT, et al. Accuracy of neutrophil gelatinase-associated lipocalin for acute kidney injury diagnosis in children : Systematic review and meta-analysis. Pediatr Nephrol 2017 Jun 14. doi : 10.1007/s00467-017-3704-6.
 
14) 伊藤秀一, 和田尚弘, 監修. 小児急性血液浄化療法ハンドブック. 東京 : 東京医学社 ; 2013.
 
15) 東京都立小児総合医療センター腎臓内科, 編. 小児のCKD/AKI実践マニュアル-透析・移植まで. 東京 : 診断と治療社 ; 2013.
 
16) 茨聡, ほか. 体外循環による新生児急性血液浄化療法ガイドライン. 日本未熟児新生児学会雑誌 2013 ; 25 : 89-97.
 
17) 伊藤克己, 監修. 小児急性血液浄化療法マニュアル. 東京 : 医学図書出版 ; 2002.
 
P.215 掲載の参考文献
1) 内閣府. 平成28年版高齢社会白書. http://www8.cao.go.jp/kourei/whitepaper/w-2016/zenbun/28pdf_index.html
 
2) Parr SK, Siew ED. Delayed consequences of acute kidney injury. Adv Chronic Kidney Dis 2016 ; 23 : 186-94.
PubMed
3) AKI (急性腎障害) 診療ガイドライン作成委員会, 編. AKI (急性腎障害) 診療ガイドライン 2016. 東京 : 東京医学社 ; 2016. p.86-90.
 
4) Hsu CY, et al. Community-based incidence of acute renal failure. Kidney Int 2007 ; 72 : 208-12.
PubMed
5) Fonarow GC, Heywood JT. The confounding issue of comorbid renal insufficiency. Am J Med 2006 ; 119 : S17-25.
PubMed
6) Denic A, et al. Structural and functional changes with the aging kidney. Adv Chronic Kidney Dis 2016 ; 23 : 19-28.
 
7) O'Sullivan ED, et al. Renal aging : Causes and consequences. J Am Soc Nephrol 2017 ; 28 : 407-20.
PubMed
8) Dinna N, et al. Acute kidney injury in the elderly. In : Neil N, et al, eds. Oxford Textbook of Clinical Nephrology. 4th ed. Oxford : Oxford University Press ; 2017. p.2038-46.
 
9) Mehta RL. Timed and targeted therapy for acute kidney injury : A glimpse of the future. Kidney Int 2010 ; 77 : 947-9.
PubMed
10) Hsu CY, et al. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int 2008 ; 74 : 101-7.
PubMed
11) Waikar SS, Bonventre JV. Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 2009 ; 20 : 672-9.
PubMed
12) Alge JL, Arthur JM. Biomarkers of AKI : A review of mechanistic relevance and potential therapeutic implications. Clin J Am Soc Nephrol 2015 ; 10 : 147-55.
 
13) Vanmassenhove J, et al. Management of patients at risk of acute kidney injury. Lancet 2017 ; 389 : 2139-51.
PubMed
14) Schmitt R, et al. Recovery of kidney function after acute kidney injury in the elderly : A systematic review and meta-analysis. Am J Kidney Dis 2008 ; 52 : 262-71.
PubMed
15) Newsome BB, et al. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med 2008 ; 168 : 609-16.
PubMed

[ 代謝異常 ]

P.225 掲載の参考文献
1) Funk GC, et al. Incidence and prognosis of dysnatremias present on ICU admission. Intensive Care Med 2010 ; 36 : 304-11.
PubMed
2) Stelfox HT, et al. The epidemiology of intensive care unit-acquired hyponatraemia and hypernatraemia in medical-surgical intensive care units. Crit Care 2008 ; 12 : R162.
PubMed
3) 行岡秀和. 電解質異常 (ナトリウム, カリウム, カルシウム, マグネシウム, リン). 岡元和文, ほか編. 集中治療専門医テキスト (電子版). 一般社団法人日本集中治療医学会 ; 2013. p.560-72.
 
4) Kraft MD, et al. Treatment of electrolyte disorders in adult patients in the intensive care unit. Am J Health Syst Pharm 2005 ; 62 : 1663-82.
PubMed
5) 清田和也. 低ナトリウム血症. 救急・集中治療 2008 ; 20 : 77-81.
 
6) Spasovski G, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Intensive Care Med 2014 ; 40 : 320-31.
PubMed
7) 谷山佳弘, 有馬秀二. 低ナトリウム血症. 臨床麻酔 2017 ; 41 : 613-8.
 
8) Lee JW. Fluid and electrolyte disturbances in critically ill patients. Electrolyte Blood Press 2010 ; 8 : 72-81.
PubMed
9) Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med 2000 ; 342 : 1581-9.
PubMed
10) Adrogue HJ, Madias NE. Hypernatremia. N Engl J Med 2000 ; 342 : 1493-9.
PubMed
11) 本多満, ほか. 高ナトリウム血症. 救急・集中治療 2008 ; 20 : 71-6.
 
P.234 掲載の参考文献
1) Gumz MJ, et al. An integrated view of potassium homeostasis. N Engl J Med 2015 ; 373 : 60-72.
 
2) Viera AJ, Wouk N. Potassium disorders : Hypokalemia and hyperkalemia. Am Fam Physician 2015 ; 92 : 487-95.
PubMed
3) Mutneja A, et al. Hypokalemia. Hyperkalemia. In : Bhat P, et al, eds. The Washington Manual of Medical Therapeutics. 35th ed. Philadelphia : Lippincott Williams & Wilkins ; 2016. p.367-71.
 
4) Preston RA. Hypokalemia. Hyperkalemia. In : Preston RA, ed. Acid-Base, Fluids, and Electrolytes Made Ridiculously Simple. 6th printing. Miami : MedMaster, Inc ; 2002. p.77-96.
 
5) 柳瀬敏彦. 副腎偶発腫瘍. 門脇孝, ほか監修. 日常診療に活かす診療ガイドライン UP-TO-DATE 2016-2017. 大阪 : メディカルレビュー社 ; 2016. p.392-6.
 
6) Kamel KS, et al. Intrarenal urea recycling leads to a higher rate of renal excretion of potassium : A hypothesis with clinical implications. Curr Opin Nephrol Hypertens 2011 ; 20 : 547-54.
PubMed
7) Petrov DB. An electrocardiographic sine wave in hyperkalemia. N Engl J Med 2012 ; 366 : 1824.
PubMed
8) Weir MR, et al. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. N Engl J Med 2015 ; 372 : 211-21.
PubMed
P.244 掲載の参考文献
1) Hansen KB, et al. Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects. J Clin Endocrinol Metab 2011 ; 96 : 447-53.
PubMed
2) American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2010 ; 33 : S62-9.
PubMed
3) McClave SA, et al ; Society of Critical Care Medicine ; American Society for Parenteral and Enteral Nutrition. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient : Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 2016 ; 40 : 159-211.
 
4) van den Berghe G, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001 ; 345 : 1359-67.
PubMed
5) Finfer S, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009 ; 360 : 1283-97.
PubMed
6) 一般社団法人 日本集中治療医学会 日本版敗血症診療ガイドライン 2016 作成特別委員会, 編. 日本版敗血症診療ガイドライン 2016. 日本集中治療医学会雑誌 2017 ; 24 Suppl 2. http://www.jsicm.org/pdf/jjsicm24Suppl2-2.pdf
 
7) Inoue S, et al. Accuracy of blood-glucose measurements using glucose meters and arterial blood gas analyzers in critically ill adult patients : Systematic review. Crit Care 2013 ; 17 : R48.
PubMed
8) Kanji S, et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med 2005 ; 33 : 2778-85.
PubMed
P.261 掲載の参考文献
1) 小澤瀞司, 福田康一郎, 監修. 標準生理学. 第8版. 東京 : 医学書院 ; 2014. p.943-52.
 
2) Henley DE, et al. Development of an automated blood sampling system for use in humans. J Med Eng Technol 2009 ; 33 : 199-208.
PubMed
3) Vermes I, et al. Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients : possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab 1995 ; 80 : 1238-42.
PubMed
4) Boonen E, et al. Reduced cortisol metabolism during critical illness. N Engl J Med 2013 ; 368 : 1477-88.
PubMed
5) Boonen E, et al. Impact of duration of critical illness on the adrenal glands of human intensive care patients. J Clin Endocrinol Metab 2014 ; 99 : 4214-22.
PubMed
6) Annane D, et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000 ; 283 : 1038-45.
PubMed
7) Charmandari E, et al. Adrenal insufficiency. Lancet 2014 ; 383 : 2152-67.
PubMed
8) Boonen E, et al. New insights into the controversy of adrenal function during critical illness. Lancet Diabetes Endocrinol 2015 ; 3 : 805-15.
PubMed
9) Yanase T, et al. Diagnosis and treatment of adrenal insufficiency including adrenal crisis : A Japan Endocrine Society clinical practice guideline. Endocrine Journal 2016 ; 63 : 765-84. 副腎クリーゼを含む副腎皮質機能低下症の診断と治療. 日本内分泌学会診療ガイドライン.
 
10) Hamrahian AH, et al. Measurements of serum free cortisol in critically ill patients. N Engl J Med. 2004 ; 350 : 1629-38.
PubMed
11) Annane D, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002 ; 288 : 862-71.
PubMed
12) Widmer IE, et al. Cortisol response in relation to the severity of stress and illness. J Clin Endocrinol Metab 2005 ; 90 : 4579-86.
 
13) Marik PE, et al ; American College of Critical Care Medicine. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients : Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008 ; 36 : 1937-49.
PubMed
14) Annane D, et al. Corticosteroids for treating sepsis. Cochrane Database Syst Rev 2015 ; (12) : CD002243.
 
P.273 掲載の参考文献
1) Marino PL. Acid-base disorders. Marino's The ICU Book. 4th ed. Philadelphia : Wolters Kluwer Health ; 2014. p.587-632.
 
2) Neligan P, Deutschman C. Perioperative acid-base balance. In : Miller RD, et al, eds. Miller's Anesthesia. 8th ed. Philadelphia : Elsevier ; 2015. p.1811-29.
 
3) 湊口俊, 藤田芳郎. 誰でもできる酸塩基平衡異常のステップ診断. 藤田芳郎, ほか編. 研修医のための輸液 水電解質 酸塩基平衡. 東京 : 中外医学社 ; 2016. p.96-107.
 
4) Berend K, et al. Physiological approach to assessment of acid-base disturbances. N Engl J Med 2014 ; 371 : 1434-45.
PubMed
5) 笠置智道, 今井裕一. 酸塩基平衡異常へのBoston学派式アプローチとその限界. 腎と透析 2015 ; 79 : 207-210.
 
6) Dubin A, et al. Comparison of three different methods of evaluation of metabolic acidbase disorders. Crit Care Med 2007 ; 35 : 1264-70.
PubMed
7) Adrogue HJ, et al. Assessing acid-base disorders. Kidney Int 2009 ; 76 : 1239-47.
PubMed
P.279 掲載の参考文献
1) Patrick J, et al. Perioperative acid-base balance. In : Miller RD, et al, eds. Miller's Anesthesia. 6th ed. Philadelphia : Elsevier Churchill Livingstone ; 2005. 武田純三, 監修. 稲田英一, ほか監訳. 周術期の酸塩基平衡. ミラー麻酔科学. 原著第6版. 東京 : メディカル・サイエンス・インターナショナル ; 2007. p.1245-57.
 
2) 森松博史, 内野滋彦. 酸塩基平衡に関する新しいアプローチ-Stewart approach. 日集中医誌 2003 ; 10 : 3-8.
 
3) Story DA. Stewart Acid-Base : A Simplified Bedside Approach. San Francisco : International Anesthesia Research Society ; 2016. p.1-5.
 
4) Fencl F, et al. Diagnosis of metabolic acid-base disturbances in critically ill patients. Am J Respir Crit Care Med 2000 ; 162 : 2246-51.
 
5) 岡原修司. 3つのindependent variables. 薬局 2014 ; 65 : 1940-42.
 
6) Park M, et al. Clinical utility of standard base excess in the diagnosis and interpretation of metabolic acidosis in critically ill patients. Braz J Med Biol Res 2008 ; 41 : 241-9.
PubMed
7) Story DA, et al. Strong ions, weak acids and base excess : A simplified Fencl-Stewart approach to clinical acid-base disorders. Br J Anaesth 2004 ; 92 : 54-60.
PubMed
P.290 掲載の参考文献
1) Stewart PA. Independent and dependent variables of acid-base control. Respir Physiol 1978 ; 33 : 9-26.
PubMed
2) Gunnerson KJ. Clinical review : The meaning of acid-base abnormalities in the intensive care unit part I-epidemiology. Crit Care 2005 ; 9 : 508-16.
PubMed
3) Kellum JA. Determinants of blood pH in health and disease. Crit Care 2000 ; 4 : 6-14.
PubMed
4) Kellum, JA. Elbers PW, eds. Stewart's Textbook of Acid-Base. 2nd ed. USA : Lulu. com ; 2009.
 
5) Figge J, et al. The role of serum proteins in acid-base equilibria. J Lab Clin Med 1991 ; 117 : 453-67.
PubMed
6) Figge J, et al. Serum proteins and acid-base equilibria : A follow-up. J Lab Clin Med 1992 ; 120 : 713-719.
PubMed
7) Staempfli HR, Constable PD. Experimental determination of net protein charge and A (tot) and K (a) of nonvolatile buffers in human plasma. J Appl Physiol (1985) 2003 ; 95 : 620-30.
 
8) Martin M, et al. Diagnosis of acid-base derangements and mortality prediction in the trauma intensive care unit : The physiochemical approach. J Trauma 2005 ; 58 : 238-43.
PubMed
9) Kellum JA, et al. Hepatic anion flux during acute endotoxemia. J Appl Physiol (1985) 1995 ; 78 : 2212-7.
PubMed
10) Kirschbaum B. Increased anion gap after liver transplantation. Am J Med Sci 1997 ; 313 : 107-10.
PubMed
11) Rocktaeschel J, et al. Acid-base status of critically ill patients with acute renal failure : Analysis based on Stewart-Figge methodology. Crit Care 2003 ; 7 : R60.
PubMed
12) Alfaro V, et al. A physical-chemical analysis of the acid-base response to chronic obstructive pulmonary disease. Can J Physiol Pharmacol 1996 ; 74 : 1229-35.
PubMed
13) LEVITIN H, et al. The pathogenesis of hypochloremia in respiratory acidosis. J Clin Invest 1958 ; 37 : 1667-75.
PubMed
14) Somogyi RB, et al. Changes in respiratory control after 5 days at altitude. Respir Physiol Neurobiol 2005 ; 145 : 41-52.
PubMed
15) Greene HM, et al. High-altitude effects on respiratory gases, acid-base balance and pulmonary artery pressures in equids. Equine Vet J Suppl 1999 ; (30) : 71-6.
PubMed
16) Dubin A, et al. Comparison of three different methods of evaluation of metabolic acid-base disorders. Crit Care Med 2007 ; 35 : 1264-70.
PubMed
17) Wilkes P. Hypoproteinemia, strong-ion difference, and acid-base status in critically ill patients. J Appl Physiol (1985) 1998 ; 84 : 1740-48.
PubMed
18) Siggaard-Andersen O, Fogh-Andersen N. Base excess or buffer base (strong ion difference) as measure of a non-respiratory acid-base disturbance. Acta Anaesthesiol Scand Suppl 1995 ; 107 : 123-8.
PubMed
19) Morimatsu H, et al. Comparison of point-of-care versus central laboratory measurement of electrolyte concentrations on calculations of the anion gap and the strong ion difference. Anesthesiology 2003 ; 98 : 1077-84.
PubMed
20) Nguyen BV, et al. The reproducibility of Stewart parameters for acid-base diagnosis using two central laboratory analyzers. Anesth Analg 2009 ; 109 : 1517-23.
PubMed
21) Antonogiannaki EM, et al. Evaluation of acid-base status in patients admitted to ED-physicochemical vs traditional approaches. Am J Emerg Med 2015 ; 33 : 378-82.
PubMed
22) Adrogue HJ, et al. Assessing acid-base disorders. Kidney Int 2009 ; 76 : 1239-47.
PubMed

書評

最近チェックした商品履歴

Loading...